Midostaurin in Patients (Pts) with Newly Diagnosed FLT3-Mutation Negative Acute Myeloid Leukemia (AML): Final Results and Measurable Residual Disease (MRD) Analyses from the Unify Trial

Jacqueline J. Cloos, Pau Montesinos, Walter Fiedler, Rouven Mueller, Juergen Krauter, Simona Sica, Joerg Westermann, Maaike E. Heidinga, Lok Lam Ngai, Yvonne J. M. Oussoren-Brockhoff, Hartmut Doehner, Mark Levis, Gert J. Ossenkoppele, Richard M. Stone, Giedre Koenen, Bourras-Rezki Bengoudifa, Yuan Cheng, Thierry Medts, Valerie Heidinger, Carolin SachsJorge Sierra

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
JournalBlood
Volume138
DOIs
Publication statusPublished - 23 Nov 2021

Cite this